Q3 2024 · 13F-HR
Lion Point Capital, LPholdings as filed
Filed 2024-11-14 · accession 0001013594-24-000964
$44.9M
Reported value
25
Positions
2024-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 464287655 | IWM | ISHARES TR | $18.2M | 40.6% | 82,500 | PUT | SOLE |
| 457669307 | INSM | INSMED INC | $3.8M | 8.49% | 52,200 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $2.9M | 6.37% | 630,000 | Common | SOLE |
| 039697107 | ARDX | ARDELYX INC | $2.5M | 5.68% | 370,000 | Common | SOLE |
| 59935V107 | MIST | MILESTONE PHARMACEUTICALS IN | $2.5M | 5.60% | 1,654,154 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $1.8M | 3.94% | 35,400 | Common | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $1.8M | 3.91% | 45,000 | PUT | SOLE |
| G52694109 | KNSA | KINIKSA PHARMACEUTICALS LTD | $1.5M | 3.42% | 61,400 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $1.2M | 2.78% | 49,000 | Common | SOLE |
| 56854Q200 | MRNS* | MARINUS PHARMACEUTICALS INC | $1.2M | 2.72% | 693,778 | Common | SOLE |
| 31447P100 | FENC | FENNEC PHARMACEUTICALS INC | $1.1M | 2.39% | 215,000 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $956,690 | 2.13% | 79,000 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $889,350 | 1.98% | 46,200 | Common | SOLE |
| G29687103 | AVDL | AVADEL PHARMACEUTICALS PLC | $839,360 | 1.87% | 64,000 | Common | SOLE |
| 09609G100 | — | BLUEBIRD BIO INC | $819,904 | 1.83% | 1,578,256 | Common | SOLE |
| 75901B107 | RGNX | REGENXBIO INC | $605,798 | 1.35% | 57,750 | Common | SOLE |
| 471871202 | JSPR | JASPER THERAPEUTICS INC | $601,920 | 1.34% | 32,000 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $378,378 | 0.84% | 7,700 | Common | SOLE |
| 08205P209 | BNTC | BENITEC BIOPHARMA INC | $358,410 | 0.80% | 39,000 | Common | SOLE |
| 03969K108 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | $326,430 | 0.73% | 35,100 | Common | SOLE |
| 81750R102 | MCRB1EUR | SERES THERAPEUTICS INC | $322,394 | 0.72% | 340,761 | Common | SOLE |
| 55028X109 | 4NX1 | LUMOS PHARMA INC | $153,209 | 0.34% | 39,589 | Common | SOLE |
| 594918104 | MSFT | MICROSOFT CORP | $43,030 | 0.10% | 100 | Common | SOLE |
| 85209E109 | — | SPRUCE BIOSCIENCES INC | $35,618 | 0.08% | 75,000 | Common | SOLE |
| 02079K107 | GOOG | ALPHABET INC | $16,719 | 0.04% | 100 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.